SCHEMBL20599561

SCHEMBL20599561

O=c1[nH]c2ccccc2c(Cl)c1-c1nc2ccc(Br)cc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 12/20 0.55
FGFR1 P11362 12/20 0.55
KDR P35968 12/20 0.55
FLT1 P17948 4/20 0.53
CHEK1 O14757 3/20 0.53
ESR1 P03372 1/20 0.51
AURKA O14965 1/20 0.46
IKBKB O14920 1/20 0.44
CHUK O15111 1/20 0.44
AKT1 P31749 1/20 0.44
AKT2 P31751 1/20 0.44
AKT3 Q9Y243 1/20 0.44
MMP2 P08253 2/20 0.44
MMP9 P14780 2/20 0.44
MMP8 P22894 2/20 0.44
MMP13 P45452 2/20 0.44
PTGES O14684 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30425807 1.00 PDGFRB (0.55) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL29783603 0.78 FGFR1 (0.78) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL20624880 0.78 FGFR1 (0.50) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL23326112 0.78 FGFR1 (0.78) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL23326153 0.77 FGFR1 (0.79) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL28401037 0.77 PDGFRB (0.47) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL1052596 0.76 FGFR1 (0.74) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL1052433 0.76 FGFR1 (0.74) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL1055032 0.76 FGFR1 (0.74) PDGFRBFGFR1KDRFLT1CHEK1
SCHEMBL21660654 0.76 PDPK1 (0.50) PDGFRBFGFR1KDRFLT1CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111032643-B Quinolinone compounds 詹森药业有限公司 2023-05-30 CN disclosed
US-11384075-B2 Quinolinone compounds JANSSEN PHARMACEUTICA NV (BE) 2022-07-12 US disclosed
US-20210139470-A1 New Quinolinone Compounds JOHNSON & JOHNSON (CHINA) INVESTMENT LTD. (CN) 2021-05-13 US disclosed
EP-3645526-A1 NEW QUINOLINONE COMPOUNDS Janssen Pharmaceutica NV (BE) 2020-05-06 EP disclosed
CN-111032643-A Quinolinone compounds 詹森药业有限公司 2020-04-17 CN disclosed
WO-2019001419-A1 NEW QUINOLINONE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2019-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139470-A1 New Quinolinone Compounds FGFR1, FGFR2, FGFR3 PDGFRB 31/4885FGFR1 1/4885KDR 28/4885
US-11384075-B2 Quinolinone compounds FGFR1, FGFR2, FGFR3 PDGFRB 23/4885FGFR1 1/4885KDR 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.